Abstract:The mechanism of SENPs involved in human oxidative stress‐related diseases. Oxidative stress is employed to depict a series of responses detrimental to normal cellular functions resulting from an imbalance between intracellular oxidants, mainly reactive oxygen species and antioxidant defenses. Oxidative stress often contributes to the development of various diseases, including cancer, cardiovascular diseases, and neurodegenerative diseases. In this process, the relationship between small ubiquitin‐like modifier (SUMO) and oxidative stress has garnered significant attention, with its posttranslational modification (PTM) frequently serving as a marker of oxidative stress status. Sentrin/SUMO‐specific proteases (SENPs), affected by alternative splicing, PTMs such as phosphorylation and ubiquitination, and various protein interactions, are crucial molecules in the SUMO process. The human SENP family has six members (SENP1–3, SENP5–7), which are classified into two categories based on sequence similarity, substrate specificity, and subcellular location. They have two core functions in the human body: first, by cleaving the precursor SUMO and exposing the C‐terminal glycine, they initiate the SUMO process; second, they can specifically recognize and dissociate SUMO proteins bound to substrates, a process known as deSUMOylation. However, the connection between deSUMOylation and oxidative stress remains a relatively unexplored area despite their strong association with oxidative diseases such as cancer and cardiovascular disease. This article aims to illustrate the significant contribution of SENPs to the oxidative stress pathway through deSUMOylation by reviewing their structure and classification, their roles in oxidative stress, and the changes in their expression and activity in several typical oxidative stress‐related diseases.

Research progression on biologic function and effect of SUMO-specific proteinase

[Sumo-Specific Protease 1 and Cancer].

Small Ubiquitin-Like Modifier Protein-Specific Protease 1 and Prostate Cancer

The Critical Roles of the SUMO-Specific Protease SENP3 in Human Diseases and Clinical Implications

SUMO proteases: from cellular functions to disease

Research progress of SENP inhibitors and SENP inhibitor bioassay methods

SUMO-specific proteases and isopeptidases of the SENP family at a glance

Progress in the Discovery of Small Molecule Modulators of DeSUMOylation.

Research progression in post-translational protein modification sumoylation in cancer

Function and regulation of ubiquitin-like SUMO system in heart

SUMO‐specific proteases: SENPs in oxidative stress‐related signaling and diseases

Global Screening of Sentrin-Specific Protease Family Substrates in SUMOylation

Exploration on effects of sumoylation on kidney diseases

Role of Desumoylation in the Development of Prostate Cancer

DeSUMOylation: An Important Therapeutic Target and Protein Regulatory Event.

SUMO Modification in Apoptosis

SUMO-Specific Protease 1 is Essential for Stabilization of HIF1α During Hypoxia

Protein SUMOylation and disease

Emerging role of SENP1 in tumorigenesis and cancer therapy

Q 7 A Progress in SUMO modification research

SUMO-specific Protease 1 Regulates the in Vitro and in Vivo Growth of Colon Cancer Cells with the Upregulated Expression of CDK Inhibitors.